Assessment of cardiovascular risk in rheumatoid arthritis: Impact of the new EULAR recommendations on the score cardiovascular risk index

Clinical Rheumatology

Volumn 31, Issue 1, 2012, Pages 35-39

  Gómez Vaquero, Carmen ^a   Robustillo, Montserrat ^a   Narváez, Javier ^a   Rodríguez Moreno, Jesús ^a   González Juanatey, Carlos ^b   Llorca, Javier ^c   Nolla, Joan Miquel ^a   González Gay, Miguel Angel ^d  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b HOSPITAL XERAL CALDE   (Spain)

^c UNIVERSITY OF CANTABRIA   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

Author keywords

Atherosclerosis; Cardiovascular risk; Ischemic cardiovascular events; Rheumatoid arthritis; SCORE

Indexed keywords

ANTIHYPERTENSIVE AGENT; DISEASE MODIFYING ANTIRHEUMATIC DRUG; GLUCOCORTICOID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TUMOR NECROSIS FACTOR ANTIBODY;

ACUTE HEART INFARCTION; ANAMNESIS; ANTIHYPERTENSIVE THERAPY; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL FEATURE; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; SMOKING; STROKE; TRANSIENT ISCHEMIC ATTACK; UNSTABLE ANGINA PECTORIS;

ARTHRITIS, RHEUMATOID; COMORBIDITY; EVIDENCE-BASED MEDICINE; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTERNATIONAL COOPERATION; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PERIPHERAL ARTERIAL DISEASE; PRACTICE GUIDELINES AS TOPIC; RISK ASSESSMENT; SPAIN; STROKE;

EID: 84856740485     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1774-6     Document Type: Article

References (20)

1. MA Gonzalez-Gay C Gonzalez-Juanatey J Martin 2005 Rheumatoid arthritis: a disease associated with accelerated atherogenesis Semin Arthritis Rheum 35 8 17 16084219 10.1016/j.semarthrit.2005.03.004 (Pubitemid 41111466)
2. JA Aviña-Zubieta HK Choi M Sadatsafavi M Etminan JM Esdaile D Lacaille 2008 Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies Arthritis Rheum 59 1690 1697 19035419 10.1002/art.24092
3. PH Dessein BI Joffe MG Veller BA Stevens M Tobias K Reddi, et al. 2005 Traditional and nontraditional cardiovascular risk factors are associated with atherosclerosis in rheumatoid arthritis J Rheumatol 32 435 442 15742434 (Pubitemid 40381413)
4. MA Gonzalez-Gay C Gonzalez-Juanatey MJ Lopez-Diaz A Piñeiro C Garcia-Porrua JA Miranda-Filloy, et al. 2007 HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis Arthritis Rheum 57 125 132 17266100 10.1002/art.22482 1:CAS:528:DC%2BD2sXis1ygu7k%3D
5. RM Conroy K Pyörälä AP Fitzgerald S Sans A Menotti G De Backer, et al. 2003 Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project Eur Heart J 24 987 1003 12788299 10.1016/S0195-668X(03)00114-3 1:STN:280:DC%2BD3s3mtFGnuw%3D%3D (Pubitemid 36712275)
6. MJ Peters DP Symmons D McCarey BA Dijkmans P Nicola TK Kvien, et al. 2010 EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis Ann Rheum Dis 69 325 331 19773290 10.1136/ard.2009.113696 1:STN:280: DC%2BC3c%2Fls12jtg%3D%3D
7. FC Arnett SM Edworthy DA Bloch DJ McShane JF Fries NS Cooper, et al. 1988 The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis Arthritis Rheum 31 315 324 3358796 10.1002/art.1780310302 1:STN:280:DyaL1c7pt1Ohsg%3D%3D (Pubitemid 18091653)
8. SH Shah LK Newby 2003 C-reactive protein: a novel marker of cardiovascular risk Cardiol Rev 11 169 179 12852794 10.1097/01.CRD.0000077906. 74217.6E (Pubitemid 36875450)
9. NJ Goodson DP Symmons DG Scott D Bunn M Lunt AJ Silman 2005 Baseline levels of C-reactive protein and prediction of death from cardiovascular disease in patients with inflammatory polyarthritis: a ten-year followup study of a primary care-based inception cohort Arthritis Rheum 52 2293 2299 16052597 10.1002/art.21204 1:CAS:528:DC%2BD2MXpslGhtrw%3D (Pubitemid 41117412)
10. ID del Rincón K Williams MP Stern GL Freeman A Escalante 2001 High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors Arthritis Rheum 44 2737 2745 11762933 10.1002/1529-0131(200112)44:12<2737::AID-ART460>3.0.CO;2-# (Pubitemid 34016192)
11. I del Rincón K Williams MP Stern GL Freeman DH O'Leary A Escalante 2003 Association between carotid atherosclerosis and markers of inflammation in rheumatoid arthritis patients and healthy subjects Arthritis Rheum 48 1833 1840 12847676 10.1002/art.11078 (Pubitemid 36828677)
12. N Sattar DW McCarey H Capell IB McInnes 2003 Explaining how "high-grade" systemic inflammation accelerates vascular risk in rheumatoid arthritis Circulation 108 2957 2963 14676136 10.1161/01.CIR. 0000099844.31524.05 (Pubitemid 37553561)
13. MA Gonzalez-Gay C Gonzalez-Juanatey A Piñeiro C Garcia-Porrua A Testa J Llorca 2005 High-grade C-reactive protein elevation correlates with accelerated atherogenesis in patients with rheumatoid arthritis J Rheumatol 32 1219 1223 15996055 1:CAS:528:DC%2BD2MXnsl2nsro%3D (Pubitemid 40995373)
14. C Gonzalez-Juanatey J Llorca A Testa J Revuelta C Garcia-Porrua MA Gonzalez-Gay 2003 Increased prevalence of severe subclinical atherosclerotic findings in long-term treated rheumatoid arthritis patients without clinically evident atherosclerotic disease Med Baltim 82 407 413 10.1097/01.md.0000101572. 76273.60 (Pubitemid 37445043)
15. C Gonzalez-Juanatey J Llorca J Martin MA Gonzalez-Gay 2009 Carotid intima-media thickness predicts the development of cardiovascular events in patients with rheumatoid arthritis Semin Arthritis Rheum 38 366 371 18336869 10.1016/j.semarthrit.2008.01.012
16. AM van Sijl MJ Peters DK Knol HC de Vet MA Gonzalez-Gay YM Smulders, et al. 2011 Carotid intima media thickness in rheumatoid arthritis as compared to control subjects: a meta-analysis Semin Arthritis Rheum 40 389 397 20889191 10.1016/j.semarthrit.2010.06.006
17. SE Gabriel CS Crowson HM Kremers MF Doran C Turesson WM O'Fallon, et al. 2003 Survival in rheumatoid arthritis: a population based analysis of trends over 40 years Arthritis Rheum 48 54 58 12528103 10.1002/art.10705 (Pubitemid 36091647)
18. FJ López-Longo D Oliver-Miñarro I de la Torre E de Rábago González-Díaz S Sánchez-Ramón M Rodríguez-Mahou, et al. 2007 Association between anti-cyclic citrullinated peptide antibodies and ischemic heart disease in patients with rheumatoid arthritis Arthritis Rheum 61 419 424 10.1002/art.24390
19. PJ Nicola H Maradit-Kremers VL Roger SJ Jacobsen CS Crowson KV Ballman, et al. 2005 The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years Arthritis Rheum 52 412 420 15692992 10.1002/art.20855 (Pubitemid 40216304)
20. TE Toms VF Panoulas KM Douglas H Griffiths N Sattar JP Smith, et al. 2010 Statin use in rheumatoid arthritis in relation to actual cardiovascular risk: evidence for substantial undertreatment of lipid-associated cardiovascular risk? Ann Rheum Dis 69 683 688 19854705 10.1136/ard.2009.115717 1:CAS:528: DC%2BC3cXltlektro%3D